Immunoglobulin G from patients with APS has been shown to stimulate vWF release from endothelial cells ex vivo [51,52], and excess vWF levels were confirmed in vivo in APS patients [53]. The gene discussed is VWF; the disease is autoimmune polyendocrinopathy.